Subscribe to Newsletter

Tumor Genomic Profiling with SureSelect Cancer Tumor-Specific Assays

With Agilent SureSelect Cancer Tumor-Specific assays, focused cancer NGS panels comprised of approximately 50 genes each, you can detect key classes of somatic alterations (SNVs, CNVs, indels, DNA translocations) from lung, colon, pancreas, kidney, and bladder tissue samples. For de novo gene fusion detection, the modular workflow allows the option to combine a SureSelect Cancer Tumor-Specific DNA assay with SureSelect Cancer CGP RNA assay (80 genes) in the same sequencing run. Obtain high-performance results optimized with error-correcting molecular barcodes, convenient enzymatic fragmentation and minimal sample input. Workflows are configurable with options to incorporate sample QC, automation, and data analysis solutions.

>> Download Data Sheet as a PDF

Find out more on Agilent's website here

>Enjoy our FREE content!

Log in or register to gain full unlimited access to all content on the The Pathologist site. It’s FREE!

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Most Popular
Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine